BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12907945)

  • 1. Protection against collagen-induced arthritis by intramuscular gene therapy with an expression plasmid for the interleukin-1 receptor antagonist.
    Kim JM; Jeong JG; Ho SH; Hahn W; Park EJ; Kim S; Yu SS; Lee YW; Kim S
    Gene Ther; 2003 Sep; 10(18):1543-50. PubMed ID: 12907945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrotransfer of human IL-1Ra into skeletal muscles reduces the incidence of murine collagen-induced arthritis.
    Jeong JG; Kim JM; Ho SH; Hahn W; Yu SS; Kim S
    J Gene Med; 2004 Oct; 6(10):1125-33. PubMed ID: 15452879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electro-gene therapy of collagen-induced arthritis by using an expression plasmid for the soluble p75 tumor necrosis factor receptor-Fc fusion protein.
    Kim JM; Ho SH; Hahn W; Jeong JG; Park EJ; Lee HJ; Yu SS; Lee CS; Lee YW; Kim S
    Gene Ther; 2003 Aug; 10(15):1216-24. PubMed ID: 12858186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of interleukin I receptor antigonist gene therapy on arthritis induced by type II collagen in mice].
    Yang G; Di C; Jiang M; Li F; Zhang Y; Yuan L; Song Q; Ma D
    Zhonghua Yi Xue Za Zhi; 2002 Jul; 82(14):990-4. PubMed ID: 12181096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3-Tat/HIV-regulated intraarticular human interleukin-1 receptor antagonist gene therapy results in efficient inhibition of collagen-induced arthritis superior to cytomegalovirus-regulated expression of the same transgene.
    Bakker AC; van de Loo FA; Joosten LA; Arntz OJ; Varley AW; Munford RS; van den Berg WB
    Arthritis Rheum; 2002 Jun; 46(6):1661-70. PubMed ID: 12115199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
    Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP
    Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; HeinegÄrd D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
    Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
    Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered susceptibility to collagen-induced arthritis in transgenic mice with aberrant expression of interleukin-1 receptor antagonist.
    Ma Y; Thornton S; Boivin GP; Hirsh D; Hirsch R; Hirsch E
    Arthritis Rheum; 1998 Oct; 41(10):1798-805. PubMed ID: 9778220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
    Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
    Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
    Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
    Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against collagen-induced arthritis by electrotransfer of an expression plasmid for the interleukin-4.
    Ho SH; Hahn W; Lee HJ; Kim DS; Jeong JG; Kim S; Yu SS; Jeon ES; Kim S; Kim JM
    Biochem Biophys Res Commun; 2004 Sep; 321(4):759-66. PubMed ID: 15358092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
    Zhou F; He X; Iwakura Y; Horai R; Stuart JM
    Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist.
    Pan RY; Chen SL; Xiao X; Liu DW; Peng HJ; Tsao YP
    Arthritis Rheum; 2000 Feb; 43(2):289-97. PubMed ID: 10693868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local expression of interleukin-1 receptor antagonist by plasmid DNA improves mortality and decreases myocardial inflammation in experimental coxsackieviral myocarditis.
    Lim BK; Choe SC; Shin JO; Ho SH; Kim JM; Yu SS; Kim S; Jeon ES
    Circulation; 2002 Mar; 105(11):1278-81. PubMed ID: 11901035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
    Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritis.
    Smeets RL; van de Loo FA; Joosten LA; Arntz OJ; Bennink MB; Loesberg WA; Dmitriev IP; Curiel DT; Martin MU; van den Berg WB
    Arthritis Rheum; 2003 Oct; 48(10):2949-58. PubMed ID: 14558102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of interleukin-10 gene electrotransfer into skeletal muscle in mice with collagen-induced arthritis.
    Saidenberg-Kermanac'h N; Bessis N; Deleuze V; Bloquel C; Bureau M; Scherman D; Boissier MC
    J Gene Med; 2003 Feb; 5(2):164-71. PubMed ID: 12539154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiostatin gene transfer as an effective treatment strategy in murine collagen-induced arthritis.
    Kim JM; Ho SH; Park EJ; Hahn W; Cho H; Jeong JG; Lee YW; Kim S
    Arthritis Rheum; 2002 Mar; 46(3):793-801. PubMed ID: 11920417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.